NeoGenomics raises target price to $24 from $21
NEO•Piper Sandler raised its target price for NeoGenomics to $24 from $21.
Related News
Alnylam Pharmaceuticals: RBC cuts target price to $280 from $345
ALNY•
Reddit: Piper Sandler cuts target price to $145 from $195
RDDT•
Roblox Corporation: Piper Sandler raises target price to $52 from $47
RBLX•
Dexcom target price raised to $97 from $90 by Canaccord Genuity
DXCM•
Jefferies raises Illumina target price to $235 from $185
ILMN•